us-fda-guidance-5bb478416e5e4fb8269ebdbd341fdbbc•Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products
us-fda-guidance-5bb478416e5e4fb8269ebdbd341fdbbcPlanning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug ProductsGuidance
Administrative guidance, not enacted legislation. This captured publisher edition preserves the listed document and attachments; later developments are not independently consolidated.
Submit Comments
Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All comments should be identified with the title of the guidance.
Setzen Sie Ihre Recherche in ChatGPT oder Claude fort
Verbinden Sie Omnilex, um den Rechtskorpus über Ihren KI-Assistenten zu durchsuchen.